Sphere Fluidics

Sphere Fluidics (Sphere) was spun out from the University of Cambridge in 2010 to commercialise novel technology based on the microfluidic handling of picolitre-scale droplets (picodroplets), which can be used to separate and encapsulate single cells for downstream analysis.

This technology is incorporated into an ultra-high-throughput single-cell sorting and analysis instrument called the Cyto-Mine®. This instrument was released in 2018 to penetrate the Single-Cell Analysis Market valued at £1.5 billion in 2018 and experiencing annual growth of 17%.

Visit website